Qube Research & Technologies (QRT)’s Treace Medical Concepts TMCI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,408	Closed	-$102K	–	3955
2025 Q2	$102K	Buy	+17,408	New	+$113K	﹤0.01%	3032
2024 Q2	–	Sell	-61,997	Closed	-$809K	–	4713
2024 Q1	$809K	Buy	61,997 +12,411	+25%	+$165K	﹤0.01%	2268
2023 Q4	$632K	Sell	49,586 -110,698	-69%	-$1.12M	﹤0.01%	2159
2023 Q3	$2.1M	Buy	160,284 +95,194	+146%	+$1.74M	0.01%	1360
2023 Q2	$1.67M	Buy	65,090 +27,477	+73%	+$709K	0.01%	1118
2023 Q1	$947K	Buy	+37,613	New	+$883K	﹤0.01%	1314

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TMCI Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 17,408 shares — an estimated $102K sold.

Qube Research & Technologies (QRT) first reported a position in TMCI in Q1 2023 and held it in 6 quarters. The position peaked at $2.1M in Q3 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

Qube Research & Technologies (QRT) reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 17,408 Treace Medical Concepts shares in Q3 2025, an estimated $102K.
Qube Research & Technologies (QRT) first reported a position in Treace Medical Concepts in Q1 2023 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Treace Medical Concepts position peaked at $2.1M in Q3 2023.
119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.